Canada has the highest rate of multiple sclerosis in the world, with an estimated 90,000 to 100,000 people living with the disease. Every day, 12 Canadians are diagnosed, most between ages 20 and 49, striking individuals during their most productive working and family-building years. “MS is the No. 1 cause of non-traumatic disability in those […]
Glioma, the most common malignant brain tumour in young adults under 50 is a devastating disease that often strikes people in their prime working years, said Samemeh Samami, senior medical science liaison at Servier, during Benefits Canada’s Drug Innovations Webinar: A spotlight on brain health. Diagnosis can turn a person’s life upside down, she noted, […]
Health Canada recently approved the first disease-modifying therapy for Alzheimer’s disease, which is a long-awaited milestone that carries significant implications for private drug plans, employers and working Canadians. “Leqembi’s approval is a turning point after two decades of no new treatment options,” said Dr. Sarah Mitchell, cognitive neurologist at Sunnybrook Health Sciences Centre and director […]